Clinuvel Pharmaceuticals Stock Market Value

Clinuvel Pharmaceuticals appears to be not too volatile, given 3 months investment horizon. Clinuvel Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We have found seventeen technical indicators for Clinuvel Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Clinuvel Pharmaceuticals' Standard Deviation of 1.87, mean deviation of 0.7698, and Risk Adjusted Performance of 0.145 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Clinuvel Pharmaceuticals holds a performance score of 10. The firm shows a Beta (market volatility) of -0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Clinuvel Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Clinuvel Pharmaceuticals is likely to outperform the market. Please check Clinuvel Pharmaceuticals' coefficient of variation, jensen alpha, as well as the relationship between the Jensen Alpha and kurtosis , to make a quick decision on whether Clinuvel Pharmaceuticals' price patterns will revert.